Lin HW - Search Results

1

Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.

Wu KC, Chu PC, Cheng YJ, Li CI, Tian J, Wu HY, Wu SH, Lai YC, Kao HH, Hsu AL, Lin HW, Lin CH. Wu KC, et al. Among authors: lin ch, lin hw. J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):2073-2087. doi: 10.1002/jcsm.13028. Epub 2022 Jun 19. J Cachexia Sarcopenia Muscle. 2022. PMID: 35718751 Free PMC article.

2

Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: a population-based study.

Chien CR, Su SY, Cohen L, Lin HW, Lee RT, Shih YC. Chien CR, et al. Among authors: lin hw. Integr Cancer Ther. 2012 Sep;11(3):221-31. doi: 10.1177/1534735411403308. Epub 2011 Apr 15. Integr Cancer Ther. 2012. PMID: 21498473 Free article.

3

Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.

Lin HW, Lin CH, Chang CK, Chou CY, Yu IW, Lin CC, Li TC, Li CI, Hsieh YW. Lin HW, et al. Among authors: lin ch, lin cc. J Formos Med Assoc. 2018 Mar;117(3):235-243. doi: 10.1016/j.jfma.2017.04.017. Epub 2017 May 23. J Formos Med Assoc. 2018. PMID: 28549592 Free article. Clinical Trial.

4

Does the Elderly's Number of Prescribed Medications across Months Matter? National Cohort versus Single-Center Cohort.

Lin HW, Li CI, Lin CH, Lin AC, Lin CC, Li TC. Lin HW, et al. Among authors: lin ch, lin ac, lin cc. Value Health Reg Issues. 2015 May;6:60-64. doi: 10.1016/j.vhri.2015.03.005. Epub 2015 May 16. Value Health Reg Issues. 2015. PMID: 29698194 Free article.

5

Valuation of the EQ-5D-5L in Taiwan.

Lin HW, Li CI, Lin FJ, Chang JY, Gau CS, Luo N, Pickard AS, Ramos Goñi JM, Tang CH, Hsu CN. Lin HW, et al. Among authors: lin fj. PLoS One. 2018 Dec 26;13(12):e0209344. doi: 10.1371/journal.pone.0209344. eCollection 2018. PLoS One. 2018. PMID: 30586400 Free PMC article.

6

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.

Cao TTB, Wu KC, Hsu JL, Chang CS, Chou C, Lin CY, Liao YM, Lin PC, Yang LY, Lin HW. Cao TTB, et al. Among authors: lin cy, lin pc, lin hw. Front Endocrinol (Lausanne). 2020 Sep 23;11:573891. doi: 10.3389/fendo.2020.573891. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071980 Free PMC article.

7

Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors.

Tsai CH, Weng JR, Lin HW, Lu MT, Liu YC, Chu PC. Tsai CH, et al. Among authors: lin hw. Cancers (Basel). 2022 Oct 7;14(19):4898. doi: 10.3390/cancers14194898. Cancers (Basel). 2022. PMID: 36230821 Free PMC article.

8

A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB. Tsai HH, et al. Among authors: lin hw. PLoS One. 2013 May 9;8(5):e64255. doi: 10.1371/journal.pone.0064255. Print 2013. PLoS One. 2013. PMID: 23671711 Free PMC article. Review.

9

Development and validation of a Chinese medication literacy measure.

Yeh YC, Lin HW, Chang EH, Huang YM, Chen YC, Wang CY, Liu JW, Ko Y. Yeh YC, et al. Among authors: lin hw. Health Expect. 2017 Dec;20(6):1296-1301. doi: 10.1111/hex.12569. Epub 2017 May 5. Health Expect. 2017. PMID: 28474423 Free PMC article.

10

Conceptualization, Development and Psychometric Evaluations of a New Medication-Related Health Literacy Instrument: The Chinese Medication Literacy Measurement.

Lin HW, Chang EH, Ko Y, Wang CY, Wang YS, Mafruhah OR, Wu SH, Chen YC, Huang YM. Lin HW, et al. Int J Environ Res Public Health. 2020 Sep 23;17(19):6951. doi: 10.3390/ijerph17196951. Int J Environ Res Public Health. 2020. PMID: 32977520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

793 results

Search Page